Reclassification of the Intermediate group classified according to HEARTSCORE taking in consideration individual genetic predisposition to Coronary artery disease.
Patient receptiveness to statin therapy is higher when presented with lifetime risk rather than 10-year risk of cardiovascular disease: insights from the PALM registry